Table 3.
Death due to worsening heart failure by treatment and gender.
| Group | Yes (%) | No (%) | Total | 
|---|---|---|---|
| male-placebo (M-P) | 358 (13.6) | 2281 (86.4) | 2639 | 
| male-drug (M-D) | 300 (11.4) | 2342 (88.6) | 2642 | 
| female-placebo (F-P) | 91 (11.9) | 673 (88.1) | 764 | 
| female-drug (F-D) | 94 (12.5) | 661 (87.5) | 755 |